- Home
- SION vs NTGR Comparison
SION vs NTGR Comparison
Compare SION & NTGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SION
- NTGR
- Stock Information
- Founded
- SION 2019
- NTGR 1996
- Country
- SION United States
- NTGR United States
- Employees
- SION N/A
- NTGR N/A
- Industry
- SION
- NTGR Telecommunications Equipment
- Sector
- SION
- NTGR Utilities
- Exchange
- SION NYSE
- NTGR Nasdaq
- Market Cap
- SION 564.4M
- NTGR 638.3M
- IPO Year
- SION 2025
- NTGR N/A
- Fundamental
- Price
- SION $13.69
- NTGR $29.33
- Analyst Decision
- SION Strong Buy
- NTGR Buy
- Analyst Count
- SION 1
- NTGR 1
- Target Price
- SION $32.00
- NTGR $29.00
- AVG Volume (30 Days)
- SION 143.7K
- NTGR 511.5K
- Earning Date
- SION 05-12-2025
- NTGR 04-30-2025
- Dividend Yield
- SION N/A
- NTGR N/A
- EPS Growth
- SION N/A
- NTGR N/A
- EPS
- SION N/A
- NTGR 0.85
- Revenue
- SION N/A
- NTGR $671,233,000.00
- Revenue This Year
- SION N/A
- NTGR $4.48
- Revenue Next Year
- SION N/A
- NTGR $5.04
- P/E Ratio
- SION N/A
- NTGR $34.69
- Revenue Growth
- SION N/A
- NTGR N/A
- 52 Week Low
- SION $7.26
- NTGR $13.22
- 52 Week High
- SION $25.19
- NTGR $31.55
- Technical
- Relative Strength Index (RSI)
- SION N/A
- NTGR 56.36
- Support Level
- SION N/A
- NTGR $28.73
- Resistance Level
- SION N/A
- NTGR $31.15
- Average True Range (ATR)
- SION 0.00
- NTGR 1.02
- MACD
- SION 0.00
- NTGR -0.22
- Stochastic Oscillator
- SION 0.00
- NTGR 26.62
About SION SIONNA THERAPEUTICS INC
Sionna Therapeutics Inc is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein to deliver clinically meaningful benefit to CF patients. CF is a progressive and life-threatening genetic disease caused by inherited mutations in the CFTR gene, which heads to insufficient CFTR function. The Company is managed as one operating segment focused on the research and development of cystic fibrosis therapies.
About NTGR NETGEAR Inc.
Netgear Inc is a provider of networking solutions. The reportable segments of the company are connected home, and Small and Medium Businesses (SMB). The Connected Home segment focuses on consumers and consists of high-performance, dependable, and easy-to-use 4G/5G mobile, Wi-Fi internet networking solutions, and smart devices such as Orbi Voice smart speakers and Meural digital canvas; and NETGEAR specializes in providing networking solutions for businesses, including wireless LAN, Pro AV applications for audio and video over Ethernet, security, and remote management.